Thymogen
Timogen / Glu-Trp
- Peptide length
- 2 amino acids
Glutamyl-tryptophan dipeptide
Open the sources to check how the studies were done and what they can support.
A short synthetic immunomodulatory peptide with animal research, including a historical radiation-carcinogenesis experiment.
- Family
- Synthetic immunomodulatory dipeptide
- Research target
- Experimental immune signaling
- Molecular form
- Glutamyl-tryptophan dipeptide
What to know about the research
An animal tumor-incidence study does not establish human cancer prevention, lifespan extension or a clinical dosing schedule.
Check the exact compound
Glu-Trp stereoisomers and linkage variants are different compounds. Do not merge Thymogen, Bestim and Thymodepressin solely by their residue names.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries